RCM
GMED icon

Raleigh Capital Management’s Globus Medical GMED Stock Holding History

Raleigh Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4
Closed -$236 – 600
2025
Q2 		$236 Buy
+4
New +$258 ﹤0.01% 563
2025
Q1 		– Sell
-310
Closed -$25.6K – 755
2024
Q4 		$25.6K Buy
310
+10
+3% +$789 0.01% 412
2024
Q3 		$21.5K Buy
+300
New +$21.2K 0.01% 425

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Raleigh Capital Management's GMED Position: Q3 2025 in Review

Raleigh Capital Management sold out of Globus Medical (GMED) in Q3 2025, closing a stake of 4 shares — an estimated $236 sold.

Raleigh Capital Management first reported a position in GMED in Q3 2024 and held it in 3 quarters. The position peaked at $25.6K in Q4 2024. 489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

  • Raleigh Capital Management reported no remaining Globus Medical position as of Q3 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 4 Globus Medical shares in Q3 2025, an estimated $236.
  • Raleigh Capital Management first reported a position in Globus Medical in Q3 2024 and held it in 3 quarters.
  • Raleigh Capital Management's Globus Medical position peaked at $25.6K in Q4 2024.
  • 489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Raleigh Capital Management's 13F filing for Q3 2025, filed 4 Nov 2025.